Tag Archives: off-label drug use

Federal Court issues ruling on drug- and device-company marketing of off-label drugs


From the New York Times today: “In a case that could have broad ramifications for the pharmaceutical industry, a federal appeals court on Monday threw out the conviction of a sales representative who sold a drug for uses not approved … Continue reading

By nickhanson | Posted in Education, Government Relations, Health Care Delivery Science, Health Policy, Research, Uncategorized | Tagged , , , , , | Leave a comment